Takeda Pharmaceutical Company Limited (4502.T) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Nikkei 225

Takeda Pharmaceutical Company Limited (4502.T) closed at JPY 6,183.00 on 2026-10-15, a change of +51.2 % over the past year, with a market capitalization of JPY 9.94T.

Takeda Pharmaceutical Company Limited recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Takeda Pharmaceutical Company Limited key figures

Previous close

JPY 6,183.00 (2026-10-15)

1-year change

+51.2 %

Market cap

JPY 9.94T

Enterprise value

JPY 14.91T

P/E ratio (trailing)

-59.17

P/E ratio (forward)

44.33

EPS (trailing)

-105.17

EPS (forward)

140.39

PEG ratio

0.44

Price to book

1.30

Revenue growth

10.2 %

Earnings growth

-9.8 %

Dividend per share (trailing)

200.00

Short ratio

n/a

Employees

47,029

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Takeda Pharmaceutical Company Limited and compare it with other stocks.